These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 37994574)

  • 41. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis.
    Shen W; Zhang X; Tang J; Zhang Z; Du R; Luo D; Liu X; Xia Y; Li Y; Wang S; Yan S; Yang W; Xiang R; Luo N; Luo Y; Li J
    Theranostics; 2021; 11(5):2297-2317. PubMed ID: 33500726
    [No Abstract]   [Full Text] [Related]  

  • 42. Cryptotanshinone attenuates the stemness of non-small cell lung cancer cells via promoting TAZ translocation from nuclear to cytoplasm.
    Jin L; Wu Z; Wang Y; Zhao X
    Chin Med; 2020; 15():66. PubMed ID: 32612672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
    Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
    Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p97/VCP is highly expressed in the stem-like cells of breast cancer and controls cancer stemness partly through the unfolded protein response.
    Li C; Huang Y; Fan Q; Quan H; Dong Y; Nie M; Wang J; Xie F; Ji J; Zhou L; Zheng Z; Wang L
    Cell Death Dis; 2021 Mar; 12(4):286. PubMed ID: 33731668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA SOX21-AS1 enhances the stemness of breast cancer cells via the Hippo pathway.
    Li L; Meng D; Wang R
    FEBS Open Bio; 2021 Jan; 11(1):251-264. PubMed ID: 33103351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
    Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
    Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.
    Zhang Y; Zhang Q; Cao Z; Huang Y; Cheng S; Pang D
    Cell Physiol Biochem; 2018; 46(4):1737-1747. PubMed ID: 29698974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
    Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
    Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells.
    Leung T; Rajendran R; Singh S; Garva R; Krstic-Demonacos M; Demonacos C
    Breast Cancer Res; 2013 Nov; 15(6):R107. PubMed ID: 24207099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness.
    Wang X; Jung YS; Jun S; Lee S; Wang W; Schneider A; Sun Oh Y; Lin SH; Park BJ; Chen J; Keyomarsi K; Park JI
    Nat Commun; 2016 Feb; 7():10633. PubMed ID: 26843124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer.
    Choi J; Park J; Cho I; Sheen Y
    Radiol Oncol; 2022 Apr; 56(2):185-197. PubMed ID: 35390248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells.
    Cheng JY; Hung JT; Lin J; Lo FY; Huang JR; Chiou SP; Wang YH; Lin RJ; Wu JC; Yu J; Yu AL
    Front Immunol; 2021; 12():791551. PubMed ID: 35046949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells.
    Yang CE; Lee WY; Cheng HW; Chung CH; Mi FL; Lin CW
    Chem Biol Interact; 2019 Apr; 302():28-35. PubMed ID: 30703373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
    Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
    Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulation of S100A10 in metastasized breast cancer stem cells.
    Yanagi H; Watanabe T; Nishimura T; Hayashi T; Kono S; Tsuchida H; Hirata M; Kijima Y; Takao S; Okada S; Suzuki M; Imaizumi K; Kawada K; Minami H; Gotoh N; Shimono Y
    Cancer Sci; 2020 Dec; 111(12):4359-4370. PubMed ID: 32976661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytochrome P450 expression and metabolic activation of cooked food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in MCF10A breast epithelial cells.
    Thomas RD; Green MR; Wilson C; Weckle AL; Duanmu Z; Kocarek TA; Runge-Morris M
    Chem Biol Interact; 2006 Apr; 160(3):204-16. PubMed ID: 16527260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer.
    Wei XL; Dou XW; Bai JW; Luo XR; Qiu SQ; Xi DD; Huang WH; Du CW; Man K; Zhang GJ
    Oncotarget; 2015 Aug; 6(25):21704-17. PubMed ID: 26023734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer.
    Zhu L; Pan R; Zhou D; Ye G; Tan W
    Cancer Manag Res; 2019; 11():2997-3007. PubMed ID: 31114347
    [No Abstract]   [Full Text] [Related]  

  • 60. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.